UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 394

Sortiert nach

Ibrutinib Resistance in Chronic Lymphocytic Leukemia

The New England journal of medicine, 2014-06, Vol.370 (24), p.2352-2354

2014

Link zum Volltext

Verfügbarkeit prüfen

Characterization of ibrutinib‐sensitive and ‐resistant mantle lymphoma cells

British journal of haematology, 2014-09, Vol.166 (6), p.849-861

2014

Link zum Volltext

Verfügbarkeit prüfen

B-Cell Lymphoma Patient-Derived Xenograft Models Enable Drug Discovery and Are a Platform for Personalized Therapy

Clinical cancer research, 2017-08, Vol.23 (15), p.4212-4223

2017

Link zum Volltext

Verfügbarkeit prüfen

SHP1 loss augments DLBCL cellular response to ibrutinib: a candidate predictive biomarker

Oncogene, 2023-02, Vol.42 (6), p.409-420

2023

Link zum Volltext

Verfügbarkeit prüfen

Multiple Genomic Alterations, Including a Novel AFF4::IRF1 Fusion Gene, in a Treatment-Refractory Blastic Plasmacytoid Dendritic-Cell Neoplasm: A Case Report and Literature Review

International journal of molecular sciences, 2024-01, Vol.25 (1), p.305

2024

Link zum Volltext

Verfügbarkeit prüfen

SYK inhibition and response prediction in diffuse large B-cell lymphoma

Blood, 2011-12, Vol.118 (24), p.6342-6352

2011

Link zum Volltext

Verfügbarkeit prüfen

JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms

Nature genetics, 2009-04, Vol.41 (4), p.446-449

2009

Link zum Volltext

Verfügbarkeit prüfen

Predicting Prognosis in Chronic Lymphocytic Leukemia in the Contemporary Era

JAMA oncology, 2015-10, Vol.1 (7), p.965

2015

Link zum Volltext

Verfügbarkeit prüfen

Ibrutinib and venetoclax target distinct subpopulations of CLL cells: implication for residual disease eradication

Blood cancer journal (New York), 2021-02, Vol.11 (2), p.39-14, Article 39

2021

Link zum Volltext

Verfügbarkeit prüfen

Validation of a Molecular Diagnostic Test for Circulating Tumor DNA by Next-Gen Sequencing

International journal of molecular sciences, 2023-11, Vol.24 (21), p.15779

2023

Link zum Volltext

Verfügbarkeit prüfen

Targeting the Hsp90-associated viral oncoproteome in gammaherpesvirus-associated malignancies

Blood, 2013-10, Vol.122 (16), p.2837-2847

2013

Link zum Volltext

Verfügbarkeit prüfen

Resistance to Bruton tyrosine kinase inhibition in chronic lymphocytic leukaemia and non‐Hodgkin lymphoma

British journal of haematology, 2023-01, Vol.200 (2), p.137-149

2023

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of B-cell receptor signaling disrupts cell adhesion in mantle cell lymphoma via RAC2

Blood advances, 2021-01, Vol.5 (1), p.185-197

2021

Link zum Volltext

Verfügbarkeit prüfen

Acute myeloid leukemia with a novel AKAP9::PDGFRA fusion transformed from essential thrombocythemia: A case report and mini review

Leukemia research reports, 2024-01, Vol.21, p.100465, Article 100465

2024

Link zum Volltext

Verfügbarkeit prüfen

Prognostic and Predictive Molecular Biomarkers in Chronic Lymphocytic Leukemia

The Journal of molecular diagnostics : JMD, 2020-09, Vol.22 (9), p.1114-1125

2020

Link zum Volltext

Verfügbarkeit prüfen

Splenic extramedullary hematopoietic proliferation in Philadelphia chromosome-negative myeloproliferative neoplasms: heterogeneous morphology and cytological composition

Modern pathology, 2012-06, Vol.25 (6), p.815-827

2012

Link zum Volltext

Verfügbarkeit prüfen

MYD88 Mutations and Sensitivity to Ibrutinib Therapy

The Journal of molecular diagnostics : JMD, 2018-03, Vol.20 (2), p.264-266

Wang, Y. Lynn

2018

Link zum Volltext

Verfügbarkeit prüfen

Female Sexual Health Training for Oncology Providers: New Applications

Sexual medicine, 2015-09, Vol.3 (3), p.189-197

2015

Link zum Volltext

Verfügbarkeit prüfen

Dual SYK/JAK inhibition overcomes ibrutinib resistance in chronic lymphocytic leukemia: Cerdulatinib, but not ibrutinib, induces apoptosis of tumor cells protected by the microenvironment

Oncotarget, 2017-02, Vol.8 (8), p.12953-12967

2017

Link zum Volltext

Verfügbarkeit prüfen

XPO1 Inhibitor Selinexor Overcomes Intrinsic Ibrutinib Resistance in Mantle Cell Lymphoma via Nuclear Retention of IκB

Molecular cancer therapeutics, 2018-12, Vol.17 (12), p.2564-2574

2018

Link zum Volltext

Verfügbarkeit prüfen

Bone marrow morphology predicts additional chromosomal abnormalities in patients with myelodysplastic syndrome with del(5q)

Human pathology, 2013-03, Vol.44 (3), p.346-356

2013

Link zum Volltext

Verfügbarkeit prüfen

Clinical Validation of a Next-Generation Sequencing Genomic Oncology Panel via Cross-Platform Benchmarking against Established Amplicon Sequencing Assays

The Journal of molecular diagnostics : JMD, 2017, Vol.19 (1), p.43-56

2017

Link zum Volltext

Verfügbarkeit prüfen

Thiazolidinedione activation of peroxisome proliferator-activated receptor gamma can enhance mitochondrial potential and promote cell survival

The Journal of biological chemistry, 2002-08, Vol.277 (35), p.31781-31788

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 394

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(347)
Mit Volltextzugriff
(359)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(232)
Life Sciences & Biomedicine
(187)
Humans
(156)
Animals
(65)
Female
(63)
Male
(60)
Biological And Medical Sciences
(57)
Mice
(43)
Medical Sciences
(40)
Physical Sciences
(33)
Biochemistry & Molecular Biology
(31)
Adult
(27)
Oncology
(27)
Pathology
(26)
Aged
(24)
Hematology
(24)
Mutation
(24)
Physics
(24)
Fundamental And Applied Biological Sciences. Psychology
(23)
Materials Science
(23)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Ibrutinib Resistance in Chronic Lymphocytic Leukemia

Characterization of ibrutinib‐sensitive and ‐resistant mantle lymphoma cells

B-Cell Lymphoma Patient-Derived Xenograft Models Enable Drug Discovery and Are a Platform for Personalized Therapy

SHP1 loss augments DLBCL cellular response to ibrutinib: a candidate predictive biomarker

Multiple Genomic Alterations, Including a Novel AFF4::IRF1 Fusion Gene, in a Treatment-Refractory Blastic Plasmacytoid Dendritic-Cell Neoplasm: A Case Report and Literature Review

SYK inhibition and response prediction in diffuse large B-cell lymphoma

Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA

JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms

Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials

Predicting Prognosis in Chronic Lymphocytic Leukemia in the Contemporary Era

Ibrutinib and venetoclax target distinct subpopulations of CLL cells: implication for residual disease eradication

Validation of a Molecular Diagnostic Test for Circulating Tumor DNA by Next-Gen Sequencing

Targeting the Hsp90-associated viral oncoproteome in gammaherpesvirus-associated malignancies

Resistance to Bruton tyrosine kinase inhibition in chronic lymphocytic leukaemia and non‐Hodgkin lymphoma

Inhibition of B-cell receptor signaling disrupts cell adhesion in mantle cell lymphoma via RAC2

Acute myeloid leukemia with a novel AKAP9::PDGFRA fusion transformed from essential thrombocythemia: A case report and mini review

Prognostic and Predictive Molecular Biomarkers in Chronic Lymphocytic Leukemia

Splenic extramedullary hematopoietic proliferation in Philadelphia chromosome-negative myeloproliferative neoplasms: heterogeneous morphology and cytological composition

MYD88 Mutations and Sensitivity to Ibrutinib Therapy

Female Sexual Health Training for Oncology Providers: New Applications

Dual SYK/JAK inhibition overcomes ibrutinib resistance in chronic lymphocytic leukemia: Cerdulatinib, but not ibrutinib, induces apoptosis of tumor cells protected by the microenvironment

XPO1 Inhibitor Selinexor Overcomes Intrinsic Ibrutinib Resistance in Mantle Cell Lymphoma via Nuclear Retention of IκB

Bone marrow morphology predicts additional chromosomal abnormalities in patients with myelodysplastic syndrome with del(5q)

Clinical Validation of a Next-Generation Sequencing Genomic Oncology Panel via Cross-Platform Benchmarking against Established Amplicon Sequencing Assays

Thiazolidinedione activation of peroxisome proliferator-activated receptor gamma can enhance mitochondrial potential and promote cell survival

Suchergebnisse filtern